Trending stocks today
Organon (OGN-N)
NYSE:OGN
17.86
0.01
(0.06%) 1d
Financials
Technical Analysis
Buy, Sell or Hold?
This summary was created by AI, based on 3 opinions in the last 12 months.
Experts have a negative outlook on Organon (OGN-N) with a downward trend, poor fundamentals, and low growth. The stock has high debt levels and has not been able to beat earnings, making it a less attractive option for investors. The company seems to be stuck in the penalty box since its spinoff from Merck, even though it pays a high dividend at a low multiple of earnings. Overall, the consensus is that Organon is not a recommended buy due to its lack of growth and high debt levels.
$11.500
Unknown
Spun off from Merck two years, but has been sitting in the penalty box. Pays a 5.5% dividend at 5x earnings.
It has no growth.
- «
- ‹
- 1
- ›
- »
Organon(OGN-N) Rating
Ranking : 3 out of 5
Bullish - Buy Signals / Votes : 1
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 2
Total Signals / Votes : 3
Organon(OGN-N) Frequently Asked Questions
What is Organon stock symbol?
Organon is a American stock, trading under the symbol OGN-N on the New York Stock Exchange (OGN). It is usually referred to as NYSE:OGN or OGN-N
Is Organon a buy or a sell?
In the last year, 3 stock analysts published opinions about OGN-N. 1 analyst recommended to BUY the stock. 2 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Organon.
Is Organon a good investment or a top pick?
Organon was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Organon.
Why is Organon stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Organon worth watching?
In the last year, there was no coverage of Organon published on Stockchase.
What is Organon stock price?
On 2024-04-18, Organon (OGN-N) stock closed at a price of $17.86.
Recently on a downward trend. Fundamentally scores 3/10. Would not recommend buying. Price target falling. Has not been able to beat earnings. Better options available for investors. High debt levels not good for dividend outlook.